1 28 May 2018 Subject: Explanation of operating result in the financial statement for the year ended 31 March 2018 To: President The Stock Exchange of Thailand With reference to the financial

ที่ กตพ Ref. DBP. 108 / 2019 August 13, 2019 Subject : Clarification on Operating Results for the 2nd quarter and 6-month Period ending June 30, 2019 To : President The Stock Exchange of Thailand

Governors of the Stock Exchange of Thailand Re: Disclosure of Information and Other Acts of Listed Companies Concerning the Acquisition and Disposition of Assets, 2004 (collectively, “the Notifications on

Registration No. : 0107535000371 No. L041/2018 8th November 2018 Subject : The explanation of operating results for the 3rd quarter 2018 Attention : The President The Stock Exchange of Thailand Dear Sir, For the

, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like

. (66)2-9063242-50 e-mail: info@halcyon.co.th No. CS-2563/002 27 February 2020 Subject: Resolution of the Board of Directors’ Meeting No.1/2020 Attention: Directors and Managers, The Stock Exchange of

transaction is deemed to be a transaction on acquisition of assets in accordance with the Notification of the Board of Governors of the Stock Exchange of Thailand Re: Disclosure of Information and Other Acts of

30, 2018 Attention: President The Stock Exchange of Thailand Oishi Group Public Company Limited and subsidiaries clarify consolidated operating results and consolidated financial statements for the

Microsoft Word - NWR 063-63_E_Q1 (Translation) No.FN-NWR 063/2563 15 May 2020 Subject : Submission of Financial Statements for the first quarter ended March 31,2020 To : President The Stock Exchange

within 21 days from the beginning of the disclosure all the listed to Bangkok Stock Exchange of Thailand but do not need any agreements from the shareholders. The company will send all the information at